Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income	$ 24,847,720	$ 5,869,100
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,809,778	17,142,915
Amortization of operating lease right-of-use assets	2,447,611	2,360,289
Amortization of financing costs	909,047	689,841
Unrealized (gain)/loss on derivatives	(2,454,234)	(433,726)
Stock-based compensation expense	658,872	647,124
Unrealized foreign currency (gain)/loss, net	581,145	4,602
Other non-cash items, net	(1,532,311)	1,386,734
Changes in operating assets and liabilities
Trade receivables, net and accrued revenue	(664,185)	(90,832)
Prepaid expenses and other current assets	(693,019)	(1,309,965)
Due from related parties	(3,153,290)	13,704,299
Inventories	76,787	35,036
Other non-current assets	60,960	(886)
Operating lease liabilities-current and long-term	(2,421,271)	(2,363,734)
Trade accounts payable	(899,490)	1,140,387
Accrued expenses and other liabilities	532,888	675,379
Due to related parties	(5,898)	(78,780)
Payments for drydocking costs	(6,736)	(1,306,463)
Net cash provided by operating activities	34,094,374	38,071,320
Cash flows from investing activities:
Payments for vessel under construction and vessel capital expenditures	(8,768,399)	(9,797,560)
Payments to acquire other fixed assets	(62,286)
Purchases of investment securities		(2,250,681)
Proceeds from sale of investment securities	2,003,458
Net cash provided by/(used in) investing activities	(6,827,227)	(12,048,241)
Cash flows from financing activities:
Proceeds from long-term debt borrowings	50,000,000
Repayment of long-term debt borrowings	(56,358,620)	(12,955,071)
Repurchase of common stock	(952,250)	(14,064,071)
Financing costs paid	(1,036,330)	(68,604)
Dividends paid	(99,912,142)
Net cash used in financing activities	(108,259,342)	(27,087,746)
Effects of exchange rates on cash and cash equivalents	(252,834)	(9,723)
Net increase/(decrease) in cash, cash equivalents, and restricted cash	(81,245,029)	(1,074,390)
Cash, cash equivalents, and restricted cash at the beginning of the period	236,836,914	84,727,199
Cash, cash equivalents, and restricted cash at the end of the period	155,591,885	83,652,809
Reconcilliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets to the total amount of such items reported in the statements of cash flows:
Cash and cash equivalents	155,518,158
Restricted cash - non-current	73,727
Cash and cash equivalents and restricted cash at end of period shown in the statement of cash flows	$ 155,591,885	$ 83,652,809